Kunisaki, Ken M <br/><br/>
Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.  [electronic resource] 

 -  Therapeutic advances in respiratory disease  Apr 2008 
 - 55-64 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1753-4658 
<br/><br/><label>Standard No.: </label>10.1177/1753465808088902  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Aged<br/>Albuterol--analogs & derivatives<br/>Androstadienes--therapeutic use<br/>Biomarkers--blood<br/>Bronchodilator Agents--therapeutic use<br/>C-Reactive Protein--analysis<br/>Female<br/>Fluticasone<br/>Forced Expiratory Volume--physiology<br/>Humans<br/>Inflammation--blood<br/>Interleukin-6--blood<br/>Interleukin-8--blood<br/>Male<br/>Nitric Oxide--metabolism<br/>Prospective Studies<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>ROC Curve<br/>Salmeterol Xinafoate<br/>Severity of Illness Index<br/>Spirometry